A review of existing and emerging digital technologies to combat the global trade in fake medicines
TK Mackey, G Nayyar - Expert opinion on drug safety, 2017 - Taylor & Francis
Introduction: The globalization of the pharmaceutical supply chain has introduced new
challenges, chief among them, fighting the international criminal trade in fake medicines. As …
challenges, chief among them, fighting the international criminal trade in fake medicines. As …
Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis
Background Uncertainty remains about the optimal monotherapy for hypertension, with
current guidelines recommending any primary agent among the first-line drug classes …
current guidelines recommending any primary agent among the first-line drug classes …
Machine learning on adverse drug reactions for pharmacovigilance
CY Lee, YPP Chen - Drug discovery today, 2019 - Elsevier
An adverse drug reaction (ADR) is an unintended response to a drug that is noxious and the
reaction has a causal relationship to the drug 1, 2, 3, 4, 5. It is disturbing that∼ 3.6% of all …
reaction has a causal relationship to the drug 1, 2, 3, 4, 5. It is disturbing that∼ 3.6% of all …
Association of ticagrelor vs clopidogrel with net adverse clinical events in patients with acute coronary syndrome undergoing percutaneous coronary intervention
Importance Current guidelines recommend ticagrelor as the preferred P2Y12 platelet
inhibitor for patients with acute coronary syndrome (ACS), primarily based on a single large …
inhibitor for patients with acute coronary syndrome (ACS), primarily based on a single large …
Comparative first-line effectiveness and safety of ACE (angiotensin-converting enzyme) inhibitors and angiotensin receptor blockers: a multinational cohort study
ACE (angiotensin-converting enzyme) inhibitors and angiotensin receptor blockers (ARBs)
are equally guideline-recommended first-line treatments for hypertension, yet few head-to …
are equally guideline-recommended first-line treatments for hypertension, yet few head-to …
Safety of hydroxychloroquine, alone and in combination with azithromycin, in light of rapid wide-spread use for COVID-19: a multinational, network cohort and self …
Background Hydroxychloroquine has recently received Emergency Use Authorization by the
FDA and is currently prescribed in combination with azithromycin for COVID-19 pneumonia …
FDA and is currently prescribed in combination with azithromycin for COVID-19 pneumonia …
Renin–angiotensin system blockers and susceptibility to COVID-19: an international, open science, cohort analysis
Background Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor
blockers (ARBs) have been postulated to affect susceptibility to COVID-19. Observational …
blockers (ARBs) have been postulated to affect susceptibility to COVID-19. Observational …
Comparative effectiveness and safety between apixaban, dabigatran, edoxaban, and rivaroxaban among patients with atrial fibrillation: a multinational population …
Background: Current guidelines recommend using direct oral anticoagulants (DOACs) over
warfarin in patients with atrial fibrillation (AF), but head-to-head trial data do not exist to …
warfarin in patients with atrial fibrillation (AF), but head-to-head trial data do not exist to …
Association between proton pump inhibitor use and gastric cancer: a population-based cohort study using two different types of nationwide databases in Korea
Objective The association between proton pump inhibitor (PPI) use and gastric cancer
related to Helicobacter pylori eradication has not been fully investigated in geographical …
related to Helicobacter pylori eradication has not been fully investigated in geographical …
Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study
Background Hydroxychloroquine, a drug commonly used in the treatment of rheumatoid
arthritis, has received much negative publicity for adverse events associated with its …
arthritis, has received much negative publicity for adverse events associated with its …